Voluntary nationwide recall: Cyclobenzaprine (Unichem – August 2025)

Sep. 2025Pharmacy Updates

Unichem Pharmaceuticals (USA), Inc. is recalling one lot, lot GMML24026A, of Cyclobenzaprine Hydrochloride Tablets USP 10 mg. Cyclobenzaprine is used for the relief of muscle spasms from certain conditions.

This drug is being recalled because a Cyclobenzaprine 10 mg (90-count) label was accidentally placed on a bottle containing Meloxicam 7.5 mg tablets. Meloxicam is a nonsteroidal anti-inflammatory drug and is used for the treatment of certain types of arthritis. Meloxicam Tablets, USP, 7.5 mg are light yellow, round, flat, beveled-edged tablets with “U & L” debossed on one side and “7.5” debossed on the other side. Using Meloxicam unknowingly if it is not prescribed for you may cause any of several different serious adverse events—particularly in people taking other nonsteroidal anti-inflammatory drugs or blood thinners, people who have allergies to Meloxicam, or people with underlying illness.

To see if your medication was recalled, contact your doctor or pharmacy where you received it or visit the FDA website below. If you have an affected lot of Cyclobenzaprine, you should stop using the product and return it to the place of purchase. If you have experienced any problems that may be related to taking this product, you should contact your doctor or health care provider.

As of Aug. 27, there had been no reports of adverse events related to this recall.

To learn more about this recall, you can take one or more of the steps below.

  • Talk to your doctor or pharmacist.
  • Call Inmar at 1-877-840-5109. TTY users should call 711. Help is available Monday through Friday from 9 a.m. to 5 p.m. CST.
  • Visit the FDA website.

Recent Announcements

CME Webinar: The State of Telehealth in 2026

Please join us for a live, CME-accredited webinar on Tuesday, Jan. 27, from noon to 1 p.m. that will share updates on the state of telehealth for 2026.
Dec. 2025Education/Webinars

Formulary updates effective Jan. 1, 2026

Review upcoming policy and operational updates
Dec. 2025Pharmacy Updates

Voluntary nationwide recall: Famotidine (Fresenius – November)

Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.
Nov. 2025Pharmacy Updates